Clinical Trial Update: ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing valganciclovir to valacyclovir for viral prophylaxis in kidney transplantation; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections
• Epstein-barr Virus Infections
• Kidney Transplantation

Drugs mentioned

• Valacyclovir (Valacyclovir)
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: University of Minnesota | Conditions: Transplantation Infection, Epstein-Barr Virus Infections | Phase 2 | Status: COMPLETED | Results posted: 2022-03-16